Recent Company News

• 07:19 PM ET Jun 18, 2026
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 09:18 AM ET Jun 18, 2026
  

  StreetAccount Summary - US Pre-market trading update

• 08:58 AM ET Jun 18, 2026
  

  StreetAccount Summary - US Initial Syndicate recap for 18-Jun

• 08:55 AM ET Jun 18, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:25 AM ET Jun 18, 2026
  

  StreetAccount Summary - US Pre-market trading

• 09:24 PM ET Jun 17, 2026
  

  Legend Biotech 7.7M-ADS secondary priced at $29.35/ADS ($33.52, 0.00)

• 05:56 PM ET Jun 17, 2026
  

  StreetAccount Summary - After-hours trading update

• 04:31 PM ET Jun 17, 2026
  

  Legend Biotech Corporation commences proposed offering of $225M in ADSs ($33.52, 0.00)

• 05:17 PM ET Jun 16, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 05:01 AM ET Jun 14, 2026
  

  Legend Biotech presents clinical proof-of-concept data for LB2501 at EHA 2026 Congress ($35.87, 0.00)